beta-naphthoflavone has been researched along with Primary Peritonitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, TL; Chu, YY; Hsu, SY; Huang, ZK; Jiang, SJ; Lin, CC; Liou, JW; Luo, WC; Peng, SY | 1 |
1 other study(ies) available for beta-naphthoflavone and Primary Peritonitis
Article | Year |
---|---|
beta-Naphthoflavone protects from peritonitis by reducing TNF-alpha-induced endothelial cell activation.
Topics: Anti-Inflammatory Agents; beta-Naphthoflavone; Cell Adhesion; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-6; MAP Kinase Signaling System; Peritonitis; Protective Agents; Reactive Oxygen Species; Signal Transduction; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2015 |